Agenda

Section VI:Probiotics,Prebiotics and Postbiotics - Session 1:Harnessing the Endogenous Power of the Microbiome to Build a New Paradigm for Metabolic Health

2027-02-23 13:30-16:40

IFF

2027-02-23 13:30-13:35
2027-02-23 13:35-14:00

Introductory Report:Digital Intelligence-Driven,Microecology Meets AI to Reshape Proactive Health and Precision Nutrition Paradigms

Prof. Yu Jun,Director of the State Key Laboratory of Digestive Disease,The Chinese University of Hong Kong
2027-02-23 14:00-14:20

Market Trends

IFF or Third-Party Market Research Company
2027-02-23 14:20-14:40

Global Food Microbial Regulatory Framework:From Scientific Assessment to Regulatory Decision-Making

Fengqin Li  Research Fellow China National Center for Food Safety Risk Assessment
2027-02-23 14:40-15:00

Global Scientific Research Trends and Outlook on Metabolic Health

Canhui Lan R-InstituteBoard Chairman/Director
2027-02-23 15:00-15:20

Research on Probiotics for Blood Glucose Reduction

Yuejian Mao Mengniu General Manager,Mircoecology R&D
2027-02-23 15:20-15:40

Microbiome and Metabolic Health Research

IFF Expert
2027-02-23 15:40-16:00

Evidence-Based Research and New Paradigms of Translational Application of Metabolic Health Probiotics

Ze XiaoLei Director of Microbial Technology R&D,BY-Health joint stock company
2027-02-23 16:00-16:20

Probiotics and Bone Metabolism

Unknown Gene Chris
2027-02-23 16:20-16:40

Metabolic Health Research

TBC

Section VI:Probiotics,Prebiotics and Postbiotics - Session 2:Clinical Efficacy and Activity-Based Standards:Elevating Probiotic Quality

2027-02-24 09:00-11:30

2027-02-24 09:00-09:20

Reconstruction of High-Activity Probiotic Standards Based on Clinical Evidence

Zhao Yunjiao  Intermediate Engineer Product Application Technology Director,Wecare Probiotics Co.,Ltd
2027-02-24 09:20-09:40

Research and Application of Whole-Chain Quality Assurance Technologies for Probiotic Viability

Dr. Yang Jiasen,Senior R&D Manager,Weikan Probiotics (Suzhou) Co.,Ltd.
2027-02-24 09:40-10:00

Bifidobacterium animalis subsp. lactis BLa80:Research and Translation of a Strain Safeguarding Infant and Toddler Health

Xu Yan  Senior R&D Engineer Wecare Probiotics Co.,Ltd
2027-02-24 10:00-10:20

Spore-Forming Probiotic BC99:Multi-Dimensional Health Regulation Based on Multi-Target Mechanisms

George Zhou  R&D Engineer Wecare Probiotics Co.,Ltd
2027-02-24 10:20-10:40

TBC

TBC
2027-02-24 10:40-11:30

Roundtable:R&D Strategies for High-Activity Quality Probiotic Strains Based on Clinical Evidence

Section VI:Probiotics,Prebiotics and Postbiotics - Session 4:The New Era of HMOs:Revisiting the Health Benefits of Bifidobacteria

2027-02-24 14:00-16:40

2027-02-24 14:00-14:20

Bifidobacteria:The Past,Present,and Future of Beneficial Human Gut Symbionts

Prof. Douwe van Sinderen,University College of Ireland,Ireland
2027-02-24 14:20-14:40

Mechanisms of Breastfeeding-Driven Bifidobacterium Colonization in the Infant Gut

Prof. Takane Katayama,Kyoto University,Japan
2027-02-24 14:40-15:00

Bifidobacterium Colonization Status in Infant Gut and Health Impacts of Bifidobacterium Deficiency

TBC
2027-02-24 15:00-15:20

Effects of Bifidobacterium Colonization on Gut Microbiota Reconstitution and Immune System Maturation

Dr. Sayaka Ishihara,Morinaga Milk Industry Biotics Research Institute
2027-02-24 15:20-15:40

Functional Exploration and Industrial Application of Early-Life Derived Bifidobacteria

Prof. Yang Bo,Jiangnan University
2027-02-24 15:40-16:00

Effects of Early-Life HRB Supplementation on Infant Gut Environment and Growth Development

Dr. Toshitaka Odamaki,Morinaga Milk Industry Biotics Research Institute
2027-02-24 16:00-16:20

AI-Empowered Clinical Research on Precision Matching of Bifidobacterium and Prebiotics

TBC
2027-02-24 16:20-16:40

Gut Microbiota and Healthy Ageing:Clinical Evidence of Bifidobacterium Effects on Healthy Ageing

Morinaga Milk Industry

Section VI:Probiotics,Prebiotics and Postbiotics - Session 6:Microbiome Balance and Host Health:From Mechanisms to Applications

2027-02-25 09:00-11:40

2027-02-25 09:00-09:20

Next-Generation Probiotic Screening Strategies and R&D Pathways Targeting Immune Regulation

He Fang  Professor West China School of Public health of Sichuan University (West China Fourth Hospital)
2027-02-25 09:20-09:40

Dietary Live Microorganism Intake Status and Health Associations Among Chinese Residents

Xiang XueSong  Research Fellow Institute of Nutrition and Health,Chinese Center for Disease Control and Prevention
2027-02-25 09:40-10:00

Gut-Musculoskeletal Axis:New Opportunities for Probiotics in Bone,Joint,and Mobility Health

Mary Farrell Scientific Affairs Manager ,Probi
2027-02-25 10:00-10:20

Scientific Evidence of Probiotic Lactobacillus casei Strain Shirota (LcS)

Yakult
2027-02-25 10:20-10:40

From Lab to Clinic:The Systematic Scientific Evidence Journey of Lacticaseibacillus rhamnosus CRL1505

Sacco System,Italy
2027-02-25 10:40-11:00

Multimodal Digital Approaches in Microbiome Research:From Baseline Stratification to Intervention Trial Evaluation

Xingyu Wang  Scientific Research Supervisor of Scientific Development Department DiPROBIO (Shanghai) Co.,Limited
2027-02-25 11:00-11:20

Mechanistic Foundations and Clinical Evidence of Liposomal Bupivacaine

Chen Yun Senior Scientist,STA,GC,dsm-firmenich
2027-02-25 11:20-11:40

ADM Enabling New Postbiotic Opportunities:Cutting-Edge Postbiotic Solutions from a White Paper Perspective

Section VI:Probiotics,Prebiotics and Postbiotics - Session 8:Next-Generation Probiotics:Akkermansia muciniphila (AKK)

2027-02-25 13:30-15:50

2027-02-25 13:30-13:50

Domestic and International Research Progress and Industrialization Status of Akkermansia muciniphila (AKK)

Lu Wenwei,Vice Dean,School of Food Science and Technology,Jiangnan University
2027-02-25 13:50-14:10

Research Progress on AKK Safety:A Systematic Review Based on Preclinical and Clinical Evidence

China National Center for Food Safety Risk Assessment
2027-02-25 14:10-14:30

Next-Generation Probiotic:Development and Application of Akkermansia muciniphila Akk11 in Metabolic Health Regulation

Liu Litai,R&D Manager,Weikan Probiotics (Suzhou) Co.,Ltd.
2027-02-25 14:30-14:50

Akkermansia muciniphila MucT®:How a scientific discovery becomes a leading innovation?

Dr Anneleen Segers,Senior Scientist,The Akkermansia Company (part of Danone Group)
2027-02-25 14:50-15:10

Mechanistic Study of AKK ONE Strain in Improving Enteritis and Cognitive Function

Li Nan,R&D Director,Sirio Pharma (China) Co.,Ltd.
2027-02-25 15:10-15:30

Clinical Study of AKK Intervention in Obese,Overweight,and PCOS Populations

Prof. Chen Tingtao,Nanchang University
2027-02-25 15:30-15:50

Mechanistic Exploration of AKK in Alzheimer's Disease Models

Prof. Ren Dayong,Jilin Agricultural University